Sickness Absence

2

Review clinical trials related to Sickness Absence. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Night Work Hours Reduction Trial

The primary aim of this study is to investigate the effects of reducing weekly working hours among employees working night shifts regularly from 38 hours 15 minutes to 36 hours on payroll-based, objective working-hour characteristics, sickness absence, and workforce retention. The secondary aim is to investigate experiences of promoting and hindering factors related to the working-hour reduction, its implementation process, and perceived benefits and challenges. The working-hour reduction will be implemented in three Finnish wellbeing services counties with different starting dates, the first being in late September 2026 and the latest in early 2027. The working-hour reduction has been agreed upon by the parties to the collective agreement for Finnish public social and health care. Thus, intervention is a so-called natural experiment in a real-life setting. The effects of the intervention will be evaluated using a quasi-experimental design with staggered, non-randomized implementation across participating counties. Administrative, payroll-based, employer-owned working-hour data, including records of sickness absences without any medical or health information and other absences (including unpaid, education, and childcare), will be used to compare changes before and during the intervention among work units participating in the working-hour reduction. The investigation will also utilize matched work units that do not participate in the reduction (i.e., intervention) as control units (i.e., continuing standard working-hour arrangements).

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Finnish Institute of Occupational HealthUpdated: Sep 30, 2026Locations: 3
Eligibility criteria

Not listed

Status: Recruiting

Implementation of the ASCEND Training for Supervisors in Dutch Small and Medium-sized Enterprises (SMEs)

This cluster randomized controlled trial (cRCT) aims to evaluate the effectiveness of the Dutch adaptation of an in-person group intervention for workplace supervisors - Advancing Supervisors' Capacity for Mental Health at Work (ASCEND) - in Dutch Small and Medium-sized Enterprises (SMEs). The ASCEND intervention is designed to equip supervisors with the skills to: i) know when to support their workers; ii) how to direct workers to support, and iii) advocate for action on mental health at work. The primary objectives of this project are to: * Assess to what extent the Dutch adaptation of the WHO-developed ASCEND intervention is effective in enhancing supervisors' confidence, responsiveness, mental health literacy, and self-care practices, and in reducing supervisor stigma towards mental health conditions within Dutch SMEs. * Evaluate the impact of the ASCEND intervention on employee outcomes, including mental health and work-related outcomes among supervisees (i.e., subordinates), as well as overall organizational absenteeism rates. * Identify barriers, facilitators, and key implementation and adoption indicators to support future opportunities for scaling up the ASCEND intervention. Researchers will compare two groups to evaluate the effectiveness of the ASCEND intervention. One group will receive the training (the intervention group), while the other group will receive the training after the final follow-up period (the control group). Data will be collected from both supervisors and their supervisees (i.e., subordinates) via online questionnaires at various time points. In addition, general organizational information, including absenteeism rates, will be gathered through a representative from each participating organization. To further explore the feasibility of scaling up the ASCEND intervention within the Netherlands, qualitative data will be collected through interviews and/or focus group discussions.

Participants needed: 148
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: VU University of AmsterdamUpdated: Jul 21, 2026Locations: 1
Eligibility criteria

Having 10 to 250 employees [+10]